2021
DOI: 10.1016/j.drugpo.2020.102908
|View full text |Cite
|
Sign up to set email alerts
|

Coordination, cooperation, and creativity within harm reduction networks in Iran: COVID-19 prevention and control among people who use drugs

Abstract: An unprecedented public health crisis confronts the world. Iran is among the hardest-hit countries, where effects of the COVID-19 pandemic are stretched across society and felt by the most marginalised people. Among people who use drugs, a comprehensive response to the crisis calls for broad collaboration, coordination, and creativity involving multiple government and non-government organisations. This commentary provides early insights into an unfolding experience, demonstrating the operational and policy imp… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
1
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…Commentaries have recently underscored that whilst MENA states have responded to this public health crisis swiftly by closing borders, restricting population movement, and instigating curfews, human rights impacts were generally ignored under the guise of continued enforcement of repressive laws and new legislation (Thiry, 2020). Some recent editorials from the MENA region (Iran, Pakistan) have documented the situation regarding harmful drug use, viral transmission, and harm reduction responses in the MENA region and have called for increased policy maker vigilance in supporting continued responses (Alavi et al, 2020;Aslam, 2020;. Iran for example has illustrated how efforts to mitigate the COVID-19 crisis among PWUD, included cessation of compulsory and residential addiction treatment admissions for a time, prisoners release schemes, and longer take-home doses provided to those on opioid agonist therapy (OAT).…”
mentioning
confidence: 99%
“…Commentaries have recently underscored that whilst MENA states have responded to this public health crisis swiftly by closing borders, restricting population movement, and instigating curfews, human rights impacts were generally ignored under the guise of continued enforcement of repressive laws and new legislation (Thiry, 2020). Some recent editorials from the MENA region (Iran, Pakistan) have documented the situation regarding harmful drug use, viral transmission, and harm reduction responses in the MENA region and have called for increased policy maker vigilance in supporting continued responses (Alavi et al, 2020;Aslam, 2020;. Iran for example has illustrated how efforts to mitigate the COVID-19 crisis among PWUD, included cessation of compulsory and residential addiction treatment admissions for a time, prisoners release schemes, and longer take-home doses provided to those on opioid agonist therapy (OAT).…”
mentioning
confidence: 99%
“…In Iran, Rebirth Charity Society led a working group to develop an interdisciplinary approach to harm reduction among people who use drugs and homeless populations. They distributed masks, sanitizer, soap, clean water, and food (Alavi et al, 2021).…”
Section: Screening and Testingmentioning
confidence: 99%
“…Drug policies across Asia, Africa, and Latin America vary enormously (Beletsky et al, 2015;Chen, 2020;Liao et al, 2013;Naamara & Muhwezi, 2014;Tran et al, 2015). Some countries in the Middle East and Asia have made harm reduction services and MOUD widely available, including Iran (Alavi et al, 2021;Ekhtiari et al, 2020) and Taiwan (Chen, 2016). Other countries maintain more regressive or even scientifically contraindicated policies (criminal justice responses masquerading as public health), such as China's routine use of coerced drug treatment (Li, 2013) and Russia's outright ban of opioid agonist MOUD, regardless of medical use (The Lancet, 2011).…”
Section: Drug Policy Before Covid-19mentioning
confidence: 99%